ARWR ARWR

Arrowhead Pharmaceuticals Stock Price

30.93
-0.57 (-1.81%)
Upgrade to Real-Time
Afterhours (Closed)
30.93
Volume 841,884
Bid Price 30.10
Ask Price 31.43
News -
Day High 31.56

Low
26.81

52 Week Range

High
84.83

Day Low 30.345
Company Name Stock Ticker Symbol Market Type
Arrowhead Pharmaceuticals Inc ARWR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.57 -1.81% 30.93 20:00:00
Open Price Low Price High Price Close Price Prev Close
31.10 30.345 31.56 30.93 31.50
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
12,615 841,884 $ 31.02 $ 26,117,517 - 26.81 - 84.83
Last Trade Time Type Quantity Stock Price Currency
17:45:26 3 $ 30.93 USD

Period:

Draw Mode:

Arrowhead Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.27B 105.85M 90.67M $ 138.29M $ -85.38M -1.36 -22.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -551.20k 6.80%

more financials information »

Arrowhead Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ARWR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week35.1035.1030.34533.71958,568-4.17-11.88%
1 Month42.6242.679930.34536.82798,661-11.69-27.43%
3 Months35.4048.4830.34540.97757,064-4.47-12.63%
6 Months47.3751.1126.8138.73810,909-16.44-34.71%
1 Year62.6984.8326.8148.01735,674-31.76-50.66%
3 Years29.1093.6619.510151.691,088,2931.836.29%
5 Years3.6093.663.0132.981,340,33727.33759.17%

Arrowhead Pharmaceuticals Description

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.


Your Recent History
NASDAQ
ARWR
Arrowhead ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now